It was a volatile week for the stock market, with the Dow Jones Industrial Average hitting an all-time high before pulling back. Wall Street pulled money away from Big Tech and into more defensive sectors, such as health care and financials. The end of the longest-ever U.S. government shutdown and expectations for interest rate cuts were also top of mind. When it was all said and done, though, stocks were little changed. For the week, the S & P 500 edged up only 0.3%, but the tech-heavy Nasdaq fell nearly 0.5%. That was the Nasdaq’s second straight week of losses. The Dow saw weekly gains of 0.3%. After closing above 48,000 for the first time on Wednesday, the 30-stock average pulled back in Thursday’s sharp market rout and ended modestly lower in Friday’s session. .SPX YTD mountain S & P 500 (SPX) year-to-date performance All-time highs Despite the market’s volatility, many Club holdings hit records this week. Wells Fargo shares hit all-time highs on Wednesday. Goldman Sachs reached new heights Thursday. The financial sector also benefited from investors seeking safety from the high valuations of many AI trades. DuPont’s stock has continued to rise since the company’s split from Qnity Electronics . Shares reached an all-time intraday high Wednesday, but lost some steam later in the week. The industrial name closed Friday slightly lower week to date. We love the new DuPont. The company operates a diversified materials business that can withstand a downturn in any single end market. DuPont’s water business is fantastic, too. Eli Lilly shares hit a series of highs this week, including on Friday. The stock closed above $1,000 for the first time ever on Wednesday. In response, Jim Cramer said Eli Lilly would soon be the first pharmaceutical company to reach a $1 trillion valuation . To achieve that, the stock would have to top $1,057. Lilly’s market cap was just over $969 billion at Friday’s close. The stock owes the bulk of its gains to the Trump administration’s recently announced GLP-1 deal with Lilly and rival Novo Nordisk . The agreement is expected to lower prices for certain weight-loss treatments for Medicare and Medicaid beneficiaries next year, in turn making Lilly’s drugs more accessible. Cramer’s buy calls On the other side of the trade are the portfolio’s laggards. During the November Monthly Meeting , Jim pointed to three that he sees as buying opportunities. These include Nike, Boeing , and Linde. Each is outside of the data center boom, a positive in a market that’s very concerned about AI-related valuations. “I cannot recall a time this year when it feels this good to be diversified among a whole host of terrific growth stocks, because growth of all kinds always works. Until now, it’s been terrific for all of 2025 to own nothing but data center, AI, nuclear, and quantum stocks,” Jim told members Thursday. “But that’s become way too risky now; it just took much longer than expected for that risk to surface.” Here’s a breakdown of…
Read More: Stocks swing wildly, Disney disappoints, and we make 6 trades